Woong-Kyung Suh

Title: Woong-Kyung Suh: Innovator in Immunology

Introduction

Woong-Kyung Suh is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of immunology through his innovative research and development. His work focuses on the modulation of immune responses, which has important implications for various diseases.

Latest Patents

Woong-Kyung Suh holds a patent for the invention titled "Downregulation of immune response by administering B7RP-2 fusion protein." This invention provides B7 Related Protein-2 (B7RP-2) polypeptides and nucleic acid molecules encoding the same. The patent also includes selective binding agents, vectors, host cells, and methods for producing B7RP-2 polypeptides. Furthermore, it offers pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with B7RP-2 polypeptides. He has 1 patent to his name.

Career Highlights

Woong-Kyung Suh is associated with Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to contribute to groundbreaking research in the field of immunology.

Collaborations

Throughout his career, Woong-Kyung Suh has collaborated with notable scientists, including Steven Kiyoshi Yoshinaga and Tak Wah Mak. These collaborations have further enhanced his research and development efforts.

Conclusion

Woong-Kyung Suh is a distinguished inventor whose work in immunology has the potential to impact the treatment of various diseases. His innovative approach and dedication to research continue to drive advancements in the field.